Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy

Heart Fail Clin. 2018 Apr;14(2):139-146. doi: 10.1016/j.hfc.2017.12.004.

Abstract

Sarcomere cardiomyopathies are genetic diseases that perturb contractile function and lead to hypertrophic or dilated myocardial remodeling. Identification of preclinical mutation carriers has yielded insights into the earliest biomechanical defects that link pathogenic variants to cardiac dysfunction. Understanding this early molecular pathophysiology can illuminate modifiable pathways to reduce the emergence of overt cardiomyopathy and curb adverse outcomes. Here, the authors review current understandings of how human hypertrophic cardiomyopathy- and hypertrophic dilated cardiomyopathy-linked mutations disrupt the normal structure and function of the sarcomere.

Keywords: Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Interacting-heads motif; Sarcomere physiology.

Publication types

  • Review

MeSH terms

  • Cardiomyopathy, Dilated / genetics*
  • Cardiomyopathy, Hypertrophic / genetics*
  • Humans
  • Sarcomeres / genetics*
  • Sarcomeres / metabolism